Killin is a p53-regulated nuclear inhibitor of DNA synthesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 14, 2008, Pages 5396-5401

  Cho, Yong Jig ^a   Liang, Peng ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Differential display; Pten

Indexed keywords

AMINO ACID; DNA; DNA BINDING PROTEIN; KILLIN; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CHEMICAL ANALYSIS; CHROMOSOME 10; CONTROLLED STUDY; DNA BINDING; DNA SYNTHESIS; DRUG INHIBITION; EUKARYOTE; GENE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN CHROMOSOME; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALS; APOPTOSIS; BINDING SITES; CELL CYCLE PROTEINS; CERCOPITHECUS AETHIOPS; CHROMOSOMES, HUMAN, PAIR 10; COS CELLS; DNA REPLICATION; DNA-BINDING PROTEINS; HUMANS; S PHASE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EUKARYOTA;

EID: 44449130834     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0705410105     Document Type: Article

References (33)

1. Levine AJ (1997) p53, the cellular gatekeeper for growth and division Cell 88:323-331.
2. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307-310.
3. Vousden K-H, Prives C (2005) p53 and prognosis: New inisights and further complexity. Cell 120:7-10.
4. El-Deiry WS (1998) Regulation of p53 downstream genes. Semin Cancer Biol 8:345-357.
5. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B (1999) Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. USA 96:14517-14522.
6. Vousden KH, Lu X (2002) Live or let die: The cell's response to p53. Nat Rev Cancer 2:594-604.
7. Liang P, Pardee AB (2003) Analyzing differential gene expression in cancer. Nature Reviews Cancer 3:869-876.
8. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
9. El-Deiry WS, Harper J-W, O'Connor P-M, Velculescu VE, Canman C-E, Jackman J, Pietenpol J-A, Burrell M, Hill D-E, Wang Y, Wiman K-G, Kastan M-B, Kohn K-W. Elledge J, Kinzler K-W, Vogelstein B (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
11. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803-1815.
12. Yu J, Zhang L (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331:851-858.
13. Polyak K, Waldman T, He TC, Kinzler K-W, Vogelstein B (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1945-1952.
14. Yu J, Wang Z, Kinzler K-W, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100:1931-1936.
15. Nahle Z, Polakoff J, Davuluri R-V, McCurrach M-E, Jacobson M-D, Narita M, Zhang M-Q, Lazebnik Y, Bar-Sagi D, Lowe S-W (2002) Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4:859-864.
16. Gottifredi V, Prives C (2005) The S phase checkpoint: When the crowd meets at the fork. Semin Cell Dev Biol 16:355-368.
17. Liang P, Pardee A-B (1992) Differential display of eukaryotic mRNA by means of the polymerase chain reaction. Science 257:967-971.
18. Cho Y, Meade J, Walden J, Guo Z, Chen X, Liang P (2001) Multicolor flourescent differential display. BioTechniques 30:562-572.
19. Liang P (2002) A decade of display Biotechniques 33:338-346.
20. Yang S, Liang P (2004) Global analysis of gene expression by differential display, a mathematical model. Mol Biotechnol 3:197-208.
21. Chen X, Ko, LJ, Jayaraman L, Prives C (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438-2451.
22. Stein S, Thomas E-K, Herzog B, Westfall M-D, Rocheleau J-V, Jackson R, Wang M, Liang P (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279:48930-48940.
23. Jackson RS, 2nd, Cho YJ, Stein S, Liang P (2007) CYFIP2, a direct p53 target, is leptomycin-B sensitive. Cell Cycle 6:95-103.
24. Jackson R-S, Cho Y-J, Liang P (2006) TIS11D is a candidate pro-apoptotic p53 target gene. Cell Cycle 5:2889-2893.
25. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak T-W (2001) Regulation of PTEN transcription by p53. Mol Cell 8:317-325.
26. Li J-J, Kelly T-J (1984) Simian virus 40 DNA replication in vitro. Proc Natl Acad Sci USA 81:6973-6977.
27. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S-I, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner S-H, Giovanella B-C, Ittmann M, Tycko B, Hibshoosh H, Wigler M-H, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
28. Steck PA, Pershouse M-A, Jasser S-A, Yung W-K, Lin H, Ligon A-H, Langford L-A, Baumgard M-L, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng D-H, Tavtigian S-V (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
29. Yoshimoto M, Cutz J-C, Nuin P-A, Joshua A-M, Bayani J, Evans A-J, Zielenska M, Squire J-A (2006) Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intraepithelial neoplasias. Cancer Genet Cytogenet 169:128-137.
30. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C (2002) Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32:355-357.
31. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
32. Miller JH (1992) Mutagenesis with EMS. A Short Course in Bacterial Genetics (Cold Spring Harbor Lab Press, Cold Spring Harbor, NY), pp 135-142.
33. Easwaran H, Leonhardt H, Cardoso M (2005) Cell cycle markers for live cell analyses. Cell Cycle 4:e53-e55.